Recursion director Borgeson sells 50,000 shares

Recursion Pharmaceuticals director Blake Borgeson reported selling 50,000 Class A shares at $4.84 each, for proceeds of $242,000, in a Form 4 filing. The filing said the sale was made under a 10b5-1 plan.